kth.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications
KTH, School of Biotechnology (BIO), Molecular Biotechnology.ORCID iD: 0000-0001-9423-0541
Show others and affiliations
2010 (English)In: FEBS Letters, ISSN 0014-5793, E-ISSN 1873-3468, Vol. 584, no 12, p. 2670-2680Article, review/survey (Refereed) Published
Abstract [en]

Affibody molecules are a class of engineered affinity proteins with proven potential for therapeutic, diagnostic and biotechnological applications. Affibody molecules are small (6.5 kDa) single domain proteins that can be isolated for high affinity and specificity to any given protein target. Fifteen years after its discovery, the Affibody technology is gaining use in many groups as a tool for creating molecular specificity wherever a small, engineering compatible tool is warranted. Here we summarize recent results using this technology, propose an Affibody nomenclature and give an overview of different HER2-specific Affibody molecules. Cumulative evidence suggests that the three helical scaffold domain used as basis for these molecules is highly suited to create a molecular affinity handle for vastly different applications.

Place, publisher, year, edition, pages
2010. Vol. 584, no 12, p. 2670-2680
Keywords [en]
Affibody molecule, Alternative scaffold, Biotherapy, Molecular imaging, Combinatorial protein engineering, Phage display
National Category
Industrial Biotechnology
Identifiers
URN: urn:nbn:se:kth:diva-27592DOI: 10.1016/j.febslet.2010.04.014ISI: 000278031800022PubMedID: 20388508Scopus ID: 2-s2.0-77953130101OAI: oai:DiVA.org:kth-27592DiVA, id: diva2:377417
Note
QC 20101214Available from: 2010-12-14 Created: 2010-12-13 Last updated: 2022-06-25Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Löfblom, JohnStåhl, Stefan

Search in DiVA

By author/editor
Löfblom, JohnStåhl, Stefan
By organisation
Molecular Biotechnology
In the same journal
FEBS Letters
Industrial Biotechnology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 171 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf